News

Press Releases

Asuragen Launches the AmplideX® PCR/CE TOMM40 Kit1 Expanding Portfolio into the Alzheimer’s and Cognitive Impairment Space
Asuragen and Thermo Fisher Scientific to Collaborate on Diagnostic Kits for 3500 Dx Series Genetic Analyzer
Asuragen to Present at 2016 Association for Molecular Pathology Annual Meeting
Asuragen Launches QuantideX® NGS RNA Lung Cancer Kit (RUO)
Asuragen Develops Armored RNA Quant® Zika Virus Control
Asuragen’s QuantideX® qPCR BCR-ABL IS Kit Receives FDA Premarket Clearance for Monitoring Minimal Residual Disease in Chronic Myeloid Leukemia
Asuragen Launches the AmplideX® PCR/CE C9orf72 Kit for High-Resolution Genotyping of GC-rich Repeat Expansions Relevant to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
Asuragen to Present Expansion of Next-Generation Sequencing Portfolio at American Association of Cancer Research Annual Meeting
Asuragen Names Colin Hill Senior Vice President of Commercial Operations
Asuragen Launches AmplideX® PCR/CE FMR1 Reporter*, a Fully Automated Software Solution for Accurate Sizing of the FMR1 CGG Repeat Region

About

Back To
Top